Verve Therapeutics (VERV) Stock Chart & Stock Price History → Next President (Not Trump. Not Biden.) (From The Freeport Society) (Ad) Free VERV Stock Alerts $5.24 -0.04 (-0.76%) (As of 05/28/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Verve Therapeutics Stock Price Performance5 Day Performance-0.76%1 Month Performance-16.29%3 Month Performance-69.27%6 Month Performance-53.21%Year-To-Date Performance-62.41%1 Year Performance-67.23% Receive VERV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Verve Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad InvestorPlaceCrypto Pioneer Says: “The last crypto bull market has begun.”Right now, there’s over $6 trillion in potential investment money waiting on the sidelines. That means this crypto bull market has a lot more room to run before it comes close to being a bubble.Click here if you’d like to learn more about these five cryptos… VERV Stock Chart for Wednesday, May, 29, 2024 VERV Chart by TradingView Verve Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/28/2024$5.28$5.24-0.76%$5.49$5.171.27 million shs$439.95 million05/27/2024$5.28$5.28$5.43$5.23934,400 shs$443.31 million05/24/2024$5.33$5.28-0.94%$5.43$5.23931,666 shs$443.31 million05/23/2024$5.60$5.33-4.82%$5.64$5.261.43 million shs$447.51 million05/22/2024$5.54$5.60+1.08%$5.74$5.381.93 million shs$470.18 million05/21/2024$5.95$5.54-6.89%$6.00$5.521.48 million shs$465.17 million Get the Latest News and Ratings for VERV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Verve Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/20/2024$5.98$5.95-0.50%$6.08$5.661.54 million shs$499.56 million05/17/2024$6.38$5.98-6.27%$6.34$5.902.19 million shs$502.08 million05/16/2024$6.23$6.38+2.41%$6.77$6.322.14 million shs$535.67 million05/15/2024$6.23$6.23$6.62$6.121.22 million shs$523.07 million05/14/2024$6.22$6.23+0.16%$6.83$6.131.49 million shs$523.07 million05/13/2024$6.01$6.22+3.49%$6.83$6.101.71 million shs$522.23 million05/10/2024$6.36$6.01-5.50%$6.43$5.881.60 million shs$504.36 million05/09/2024$6.08$6.36+4.61%$6.73$6.131.96 million shs$533.73 million05/08/2024$6.16$6.08-1.30%$6.29$5.991.46 million shs$510.23 million05/07/2024$6.41$6.16-3.90%$6.46$6.05886,791 shs$516.95 million05/06/2024$6.41$6.41$6.73$6.28811,985 shs$537.95 million05/03/2024$6.15$6.41+4.23%$7.00$6.281.39 million shs$537.93 million05/02/2024$6.00$6.15+2.50%$6.25$6.00949,350 shs$516.11 million05/01/2024$6.01$6.00-0.17%$6.56$5.841.76 million shs$504.38 million04/30/2024$6.26$6.01-3.99%$6.31$5.961.02 million shs$502.56 million04/29/2024$6.16$6.26+1.62%$6.54$6.11933,090 shs$523.46 million04/26/2024$6.22$6.16-0.96%$6.41$6.02791,349 shs$515.10 million04/25/2024$6.58$6.22-5.47%$6.35$6.051.22 million shs$520.12 million04/24/2024$6.88$6.58-4.36%$6.92$6.531.00 million shs$550.22 million04/23/2024$6.91$6.88-0.43%$7.41$6.81962,924 shs$575.31 million04/22/2024$6.64$6.91+4.07%$7.03$6.46909,064 shs$577.81 million04/19/2024$6.66$6.64-0.30%$6.80$6.421.10 million shs$555.24 million04/18/2024$6.74$6.66-1.19%$6.85$6.531.25 million shs$556.91 million04/17/2024$7.14$6.74-5.60%$7.27$6.721.15 million shs$563.60 million04/16/2024$7.31$7.14-2.33%$7.26$7.04691,035 shs$597.05 million04/15/2024$7.60$7.31-3.82%$7.73$7.131.37 million shs$611.26 million04/12/2024$8.07$7.60-5.82%$8.02$7.541.19 million shs$635.51 million04/11/2024$8.01$8.07+0.75%$8.40$7.901.08 million shs$674.81 million04/10/2024$8.75$8.01-8.46%$8.32$7.761.72 million shs$669.80 million04/09/2024$8.40$8.75+4.17%$8.77$8.37872,383 shs$731.68 million04/08/2024$8.52$8.40-1.41%$8.75$8.241.03 million shs$702.40 million04/05/2024$8.68$8.52-1.84%$8.75$8.181.38 million shs$712.44 million04/04/2024$8.71$8.68-0.34%$9.23$8.641.63 million shs$725.81 million04/03/2024$8.32$8.71+4.69%$8.92$8.172.73 million shs$728.33 million4 Cryptos BETTER than Bitcoin (Ad)Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than BitcoinClick For My #1 FREE Crypto for 202404/02/2024$12.79$8.32-34.95%$9.28$7.3610.02 million shs$695.72 million04/01/2024$13.28$12.79-3.69%$13.24$12.52868,948 shs$1.07 billion03/29/2024$13.28$13.28$13.63$12.94647,690 shs$1.11 billion03/28/2024$13.19$13.28+0.68%$13.63$12.96647,590 shs$1.11 billion03/27/2024$12.79$13.19+3.13%$13.24$12.65633,369 shs$1.10 billion03/26/2024$13.16$12.79-2.81%$13.43$12.77663,883 shs$1.07 billion03/25/2024$12.97$13.16+1.46%$13.23$12.81524,538 shs$1.10 billion03/22/2024$13.21$12.97-1.82%$13.24$12.80584,615 shs$1.08 billion03/21/2024$13.38$13.21-1.27%$14.26$13.05888,884 shs$1.10 billion03/20/2024$13.01$13.38+2.84%$13.54$12.67780,762 shs$1.12 billion03/19/2024$13.31$13.01-2.25%$13.48$12.89870,559 shs$1.09 billion03/18/2024$13.81$13.31-3.62%$13.81$12.82878,195 shs$1.11 billion03/15/2024$13.60$13.81+1.54%$14.03$13.474.71 million shs$1.15 billion03/14/2024$14.34$13.60-5.16%$14.30$13.39971,086 shs$1.14 billion03/13/2024$13.92$14.34+3.02%$14.51$13.85950,441 shs$1.20 billion03/12/2024$14.42$13.92-3.47%$14.57$13.601.07 million shs$1.16 billion03/11/2024$14.96$14.42-3.61%$15.55$14.23877,426 shs$1.21 billion03/08/2024$14.94$14.96+0.13%$16.03$14.72644,869 shs$1.25 billion03/07/2024$15.07$14.94-0.86%$15.81$14.91937,113 shs$952.43 million03/06/2024$15.14$15.07-0.46%$15.62$14.921.19 million shs$960.71 million03/05/2024$15.84$15.14-4.42%$16.05$14.841.11 million shs$965.22 million03/04/2024$16.29$15.84-2.76%$16.43$15.371.31 million shs$1.01 billion03/01/2024$17.05$16.29-4.46%$17.33$16.151.81 million shs$1.04 billion02/29/2024$17.96$17.05-5.07%$19.34$16.891.88 million shs$1.09 billion02/28/2024$17.54$17.96+2.39%$18.96$16.552.15 million shs$1.14 billion Related Companies: Adlai Nortye Stock Chart Korro Bio Stock Chart Esperion Therapeutics Stock Chart Fulcrum Therapeutics Stock Chart PepGen Stock Chart Oculis Stock Chart Applied Therapeutics Stock Chart Annexon Stock Chart Theravance Biopharma Stock Chart Neurogene Stock Chart Receive VERV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Verve Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VERV) was last updated on 5/29/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaYou won't believe what Citigroup just did to it's depositorsAmerican Alternative4 Cryptos BETTER than BitcoinTrue Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsA once-in-a-century investment opportunityStansberry ResearchWrite this ticker symbol down…StocksToTradeBill Clinton Backing Biden Replacement???The Freeport SocietyMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Verve Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.